Wnt/b-catenin inhibitors and methods of use
US9469606B2 · kind B2 · utility
0Cited by
2References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 25, 2012 |
| Grant date | Oct 18, 2016 |
| Priority date | — |
| Expiry date | Oct 25, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C317/32
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This disclosure relates to inhibitors of the Wni pathway, and compositions comprising the same, as well as to their use in the treatment of disorders characterized by the activation of Writ pathway signaling (e.g., cancer), as well as to the modulation of cellular events mediated by VVnt pathway signaling.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.